[go: up one dir, main page]

BR112014027841A8 - Derivado de pirazola e o uso do mesmo para fins médicos - Google Patents

Derivado de pirazola e o uso do mesmo para fins médicos

Info

Publication number
BR112014027841A8
BR112014027841A8 BR112014027841A BR112014027841A BR112014027841A8 BR 112014027841 A8 BR112014027841 A8 BR 112014027841A8 BR 112014027841 A BR112014027841 A BR 112014027841A BR 112014027841 A BR112014027841 A BR 112014027841A BR 112014027841 A8 BR112014027841 A8 BR 112014027841A8
Authority
BR
Brazil
Prior art keywords
medical purposes
present
pyrazole derivative
constipation
prevention
Prior art date
Application number
BR112014027841A
Other languages
English (en)
Other versions
BR112014027841B1 (pt
BR112014027841A2 (pt
Inventor
Hidetoshi Isawa
Itaru Miyashita
Masaaki Takemura
Masayuki Isaji
Yukihiko Hotei
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Publication of BR112014027841A2 publication Critical patent/BR112014027841A2/pt
Publication of BR112014027841A8 publication Critical patent/BR112014027841A8/pt
Publication of BR112014027841B1 publication Critical patent/BR112014027841B1/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02Heterocyclic radicals containing only nitrogen as ring hetero atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

derivado de pirazola e o uso do mesmo para fins médicos. a presente invenção proporciona derivados de pirazola, o uso dos mesmos para fins médicos e assim por diante. mais particularmente, a presente invenção se refere a produtos farmacêuticos úteis para a prevenção ou o tratamento de constipação, que compreende como um ingrediente ativo 3-(3-{4-[3-(beta-d-glicopiranosiloxi)-5-isopropil-1h-pirazol-4-ilmetil]-3-metilfenoxi}propilamino)-2,2-dimetilpropionamida, ou um sal farmaceuticamente aceitável do mesmo. os produtos farmacêuticos da pre-sente invenção exercem um efeito de aumentar a frequência do movimento dos intestinos ou semelhante, e são úteis para a prevenção ou o tratamento de constipação.
BR112014027841-5A 2012-05-07 2013-05-02 Uso de derivados de pirazola na fabricação de um fármaco para prevenir ou tratar constipação BR112014027841B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2012-105847 2012-05-07
JP2012105847 2012-05-07
PCT/JP2013/062755 WO2013168671A1 (ja) 2012-05-07 2013-05-02 ピラゾール誘導体及びその医薬用途

Publications (3)

Publication Number Publication Date
BR112014027841A2 BR112014027841A2 (pt) 2017-06-27
BR112014027841A8 true BR112014027841A8 (pt) 2021-09-28
BR112014027841B1 BR112014027841B1 (pt) 2022-08-09

Family

ID=49550709

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014027841-5A BR112014027841B1 (pt) 2012-05-07 2013-05-02 Uso de derivados de pirazola na fabricação de um fármaco para prevenir ou tratar constipação

Country Status (16)

Country Link
US (2) US9273085B2 (pt)
EP (1) EP2848254B1 (pt)
JP (2) JP5663699B2 (pt)
KR (1) KR101868991B1 (pt)
CN (1) CN104284665B (pt)
AU (1) AU2013258566B2 (pt)
BR (1) BR112014027841B1 (pt)
CA (1) CA2872002C (pt)
DK (1) DK2848254T3 (pt)
ES (1) ES2601127T3 (pt)
HK (1) HK1204773A1 (pt)
MX (1) MX359988B (pt)
PL (1) PL2848254T3 (pt)
PT (1) PT2848254T (pt)
RU (1) RU2602739C2 (pt)
WO (1) WO2013168671A1 (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3400944T3 (da) 2010-11-04 2020-10-12 Albireo Ab Ibat-inhibitorer til behandling af leversygdomme
JP5663699B2 (ja) * 2012-05-07 2015-02-04 キッセイ薬品工業株式会社 ピラゾール誘導体及びその医薬用途
EP2952206B1 (en) 2013-02-04 2018-10-24 Taisho Pharmaceutical Co., Ltd. Prophylactic or therapeutic drug for constipation
WO2015199146A1 (ja) * 2014-06-25 2015-12-30 味の素株式会社 固形製剤及びその安定化方法
CN106659726A (zh) 2014-06-25 2017-05-10 Ea制药株式会社 固体制剂及其着色防止或着色减少方法
CN112469407B (zh) 2018-03-28 2024-10-01 阿沃林特有限公司 用于治疗餐后低血糖症的方法
ES2942443T3 (es) 2018-06-05 2023-06-01 Albireo Ab Compuestos de benzotia(di)azepina y su uso como moduladores de ácidos biliares
CR20210027A (es) 2018-06-20 2021-04-29 Albireo Ab Formulación farmacéutica de odevixibat
US11801226B2 (en) 2018-06-20 2023-10-31 Albireo Ab Pharmaceutical formulation of odevixibat
US11549878B2 (en) 2018-08-09 2023-01-10 Albireo Ab In vitro method for determining the adsorbing capacity of an insoluble adsorbant
US11007142B2 (en) 2018-08-09 2021-05-18 Albireo Ab Oral cholestyramine formulation and use thereof
US10975045B2 (en) 2019-02-06 2021-04-13 Aibireo AB Benzothiazepine compounds and their use as bile acid modulators
PE20212251A1 (es) 2019-02-06 2021-11-24 Albireo Ab Compuestos de benzotiadiazepina y su uso como moduladores del acido biliar
US10941127B2 (en) 2019-02-06 2021-03-09 Albireo Ab Benzothiadiazepine compounds and their use as bile acid modulators
JP2023504644A (ja) 2019-12-04 2023-02-06 アルビレオ・アクチボラグ ベンゾチアジアゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用
JP2023504643A (ja) 2019-12-04 2023-02-06 アルビレオ・アクチボラグ ベンゾチア(ジ)アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用
CN114786772B (zh) 2019-12-04 2024-04-09 阿尔比里奥公司 苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途
US11014898B1 (en) 2020-12-04 2021-05-25 Albireo Ab Benzothiazepine compounds and their use as bile acid modulators
ES2973549T3 (es) 2019-12-04 2024-06-20 Albireo Ab Compuestos de benzoti(di)azepina y su uso como moduladores de los ácidos biliares
EP4188541B1 (en) 2020-08-03 2024-12-25 Albireo AB Benzothia(di)azepine compounds and their use as bile acid modulators
EP4243831A1 (en) 2020-11-12 2023-09-20 Albireo AB Odevixibat for treating progressive familial intrahepatic cholestasis (pfic)
JP2024500309A (ja) 2020-12-04 2024-01-09 アルビレオ エービー ベンゾチア(ジ)アゼピン化合物および胆汁酸モジュレータとしてのその使用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004137245A (ja) 2002-08-23 2004-05-13 Kissei Pharmaceut Co Ltd ピラゾール誘導体、それを含有する医薬組成物、その医薬用途及びその製造中間体
AU2007243466B2 (en) * 2006-04-26 2012-01-19 F. Hoffmann-La Roche Ag Phosphoinositide 3-kinase inhibitor compounds and pharmaceutical compositions containing them
ES2548578T3 (es) * 2007-12-27 2015-10-19 Kissei Pharmaceutical Co., Ltd. Monosebacato de un derivado de pirazol
ES2385185T3 (es) 2008-04-16 2012-07-19 Kissei Pharmaceutical Co., Ltd. Hemifumarato de un derivado de pirazol
AR087701A1 (es) 2011-08-31 2014-04-09 Japan Tobacco Inc Derivados de pirazol con actividad inhibidora de sglt1
JP5663699B2 (ja) * 2012-05-07 2015-02-04 キッセイ薬品工業株式会社 ピラゾール誘導体及びその医薬用途

Also Published As

Publication number Publication date
WO2013168671A1 (ja) 2013-11-14
JP6105546B2 (ja) 2017-03-29
BR112014027841B1 (pt) 2022-08-09
ES2601127T3 (es) 2017-02-14
AU2013258566B2 (en) 2017-03-16
KR101868991B1 (ko) 2018-06-19
KR20150013671A (ko) 2015-02-05
US20160129031A1 (en) 2016-05-12
EP2848254B1 (en) 2016-08-03
US20150141631A1 (en) 2015-05-21
EP2848254A1 (en) 2015-03-18
DK2848254T3 (en) 2016-10-31
US9273085B2 (en) 2016-03-01
CA2872002C (en) 2019-01-15
RU2014149181A (ru) 2016-06-27
EP2848254A4 (en) 2015-07-15
RU2602739C2 (ru) 2016-11-20
MX2014013696A (es) 2015-02-05
CA2872002A1 (en) 2013-11-14
JPWO2013168671A1 (ja) 2016-01-07
JP2015083580A (ja) 2015-04-30
PT2848254T (pt) 2016-10-05
PL2848254T3 (pl) 2017-03-31
CN104284665A (zh) 2015-01-14
AU2013258566A1 (en) 2014-11-27
JP5663699B2 (ja) 2015-02-04
MX359988B (es) 2018-10-18
CN104284665B (zh) 2016-11-16
BR112014027841A2 (pt) 2017-06-27
US9694027B2 (en) 2017-07-04
HK1204773A1 (en) 2015-12-04

Similar Documents

Publication Publication Date Title
BR112014027841A8 (pt) Derivado de pirazola e o uso do mesmo para fins médicos
EA201491060A1 (ru) Новые производные трифторметилоксадиазола и их применение для лечения заболевания
CY1118379T1 (el) Αναστολεις ιου ηπατιτιδας c
EA201490228A1 (ru) Новые производные трифторметилоксадиазола и их применение для лечения заболевания
BR112014031068A2 (pt) derivados piridinona e piridazinona
BR112016005270A2 (pt) compostos de aza-piridona, composições farmacêuticas e seus usos
BR112015030315A2 (pt) derivado de 4-alquinilimidazol e medicamento compreendendo o mesmo como ingrediente ativo
BR112015019590A2 (pt) derivados de ácido betulínico modificado com c-3 alquila e alquenila úteis no tratamento de hiv
BR112015030399B8 (pt) Derivados heterocíclicos, uso dos referidos derivados e composição farmacêutica para a prevenção ou tratamento de doenças associadas com a ativação da proteína stat3
CO6491060A2 (es) Compuestos y composiciones para el tratamiento de enfermedades parasitarias
JO3263B1 (ar) مشتق إندان سلفاميد جديد
DOP2014000059A (es) Derivados de estra–1,3,5(10),16–tetraen–3–carboxamida, procedimientos para su preparación, preparados farmacéuticos que los contienen, así como su uso para la preparación de medicamentos
CU20110088A7 (es) Derivados de anilina-pirimidina sustituidos con sulfoximina como inhibidores de quinasas dependientes de ciclina (cdk), producción y uso de los mismos como productos medicinales
BR112016026552A8 (pt) derivados de carboxamida, seus usos, composição farmacêutica, e combinação
CY1119542T1 (el) Προϊον μικρονισμου που περιλαμβανει οξεικη ουλιπρισταλη
BR112015015250A2 (pt) derivados de pirrolidina, composições farmacêuticas e usos dos mesmos
BR112015004091A2 (pt) formulação de cápsula de compósito farmacêutico que compreende irbesartan e inibidor de hmg-coa redutase
MY169266A (en) Solid state forms of n-((s)-2,3-dihydroxy-propyl)-3-(2-fluoro-4-iodo-phenylamino)-isonicotinamide
BR112017009850A2 (pt) composto, composição, e, uso de uma quantidade melhoradora de hiv de um composto
BR112012024346A2 (pt) agente terapêutico ou agente profilático para a doença de alzheimer
BR112017013031A2 (pt) derivados de imidazopiridazina ligados à heterociclila como inibidores de pi3kbeta
WO2016016820A3 (en) Anionically modified n-sulfonic polyallylamine derivative, pharmaceutical composition comprising the n-sulfonic polyallylamine derivative as the active substance and use of said derivate for the production of a medicine
EA201200799A1 (ru) Гепатопротекторное средство
BR112016030599A8 (pt) novos derivados de aminoalquilbenzotiazepina e suas utilizações
CU20150065A7 (es) Compuestos derivados de bencil 4-((2-(triazol-5-il)acetamido)metil)piperidin-1- carboxilato activos como inhibidores de autotaxina

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 02/05/2013, OBSERVADAS AS CONDICOES LEGAIS